Brookline Capital Management Weighs in on electroCore, Inc.’s Q3 2024 Earnings (NASDAQ:ECOR)

electroCore, Inc. (NASDAQ:ECORFree Report) – Brookline Capital Management boosted their Q3 2024 earnings per share estimates for electroCore in a report issued on Wednesday, August 7th. Brookline Capital Management analyst T. Bussian now forecasts that the company will post earnings of ($0.21) per share for the quarter, up from their prior forecast of ($0.25). The consensus estimate for electroCore’s current full-year earnings is ($1.38) per share. Brookline Capital Management also issued estimates for electroCore’s Q4 2024 earnings at ($0.11) EPS and FY2024 earnings at ($1.03) EPS.

electroCore (NASDAQ:ECORGet Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.01. The business had revenue of $6.14 million for the quarter, compared to analysts’ expectations of $5.85 million. electroCore had a negative net margin of 88.12% and a negative return on equity of 219.33%. During the same period in the prior year, the company posted ($1.03) EPS.

electroCore Trading Down 1.4 %

ECOR stock opened at $5.98 on Monday. The company has a market cap of $35.92 million, a price-to-earnings ratio of -2.10 and a beta of 0.55. The firm has a 50 day moving average of $6.20 and a 200-day moving average of $6.45. electroCore has a 12-month low of $4.50 and a 12-month high of $8.08.

Insider Activity

In other electroCore news, CEO Daniel S. Goldberger bought 38,505 shares of the business’s stock in a transaction on Wednesday, June 5th. The stock was bought at an average price of $6.43 per share, for a total transaction of $247,587.15. Following the completion of the transaction, the chief executive officer now owns 249,565 shares in the company, valued at approximately $1,604,702.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 13.14% of the company’s stock.

Hedge Funds Weigh In On electroCore

A number of institutional investors have recently made changes to their positions in ECOR. Renaissance Technologies LLC increased its position in electroCore by 3.4% during the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company’s stock worth $442,000 after purchasing an additional 2,270 shares in the last quarter. International Assets Investment Management LLC boosted its stake in shares of electroCore by 27.9% during the 2nd quarter. International Assets Investment Management LLC now owns 67,820 shares of the company’s stock worth $436,000 after purchasing an additional 14,800 shares during the last quarter. Finally, PFG Investments LLC purchased a new stake in shares of electroCore during the first quarter worth about $111,000. 26.74% of the stock is owned by institutional investors and hedge funds.

About electroCore

(Get Free Report)

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.

Further Reading

Earnings History and Estimates for electroCore (NASDAQ:ECOR)

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.